Illumina-University of Melbourne Partnership

Partnering to provide the infrastructure, expertise, systems and analysis to translate and implement genomics into routine clinical care.

Partnership team

Genomics-driven personalised care presents an incredible opportunity to transform patient outcomes and create substantial efficiencies for the healthcare system.

Illumina and the University of Melbourne are partnering affordable, scaleable next-generation sequencing with the research expertise, infrastructure, systems and analysis needed to implement genomics into routine clinical care.

Based in the Melbourne Biomedical Precinct, our collaborative, cross-disciplinary approach translates evidence-based advancements into the clinic, supporting local training and jobs.​

The Illumina-University of Melbourne partnership will lift local genomics research and clinical trials to a global scale and quality, driving collaboration within the Precinct through the development of three core enabling platforms in clinical genomics, bioinformatics, and health economics.

Announcing The Illumina-University of Melbourne Genomics Hub

Illumina and University of Melbourne, together with Invest Victoria, are excited to launch The Illumina-University of Melbourne Genomics Hub. Find out more about how the Hub will become a key driver in building workforces and businesses of the future, delivering first-hand, practical experience and fostering a pipeline of commercially focused genomics innovation projects.

The core enabling platforms

The establishment of three core enabling platforms is vital to fostering a pipeline of commercially focused genomic innovation projects. Together with Illumina’s commercial expertise and global connections, the core platforms will enable the Melbourne Biomedical Precinct to capitalise on its competitive advantage in genomics research thanks to our world-leading researchers. The platforms will be underpinned by cloud-based informatics infrastructure enabling the delivery of genomics at scale for flagship and future innovation projects.

Latest news

Loading...